Expression of specific microRNAs in tissue and plasma in colorectal cancer
Open Access
- 15 May 2023
- journal article
- research article
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 57 (3) , 147-157
Abstract
Background: MicroRNAs (miRNA/miR) play significant roles in the regulation of cell differentiation, cell cycle progression, and apoptosis. They become dysregulated during carcinogenesis and are eventually released into the circulation, enabling their detection in body fluids. Thus, this study compared the miRNA expression in tissue and plasma samples of colorectal cancer (CRC) patients and clinically healthy controls and determined miRNA expression as a potential CRC biomarker.Methods: Using quantitative reverse transcription polymerase chain reaction (RT-qPCR), miR-21-5p, miR-29a-3p, miR-92a-3p, miR-135b-5p, miR-196b-5p, and miR-197-3p, expression was analyzed and compared between the malignant (n = 41) and the adjacent neoplasm free mucosal tissues (n = 41) of CRC patients. The findings were validated in plasma samples (n = 36) collected from the same CRC patients prior to surgery or any form of treatment and compared to plasma from their age and sex-matched controls (n = 36).Results: MiR-21-5p, miR-29a-3p, miR-92a-3p, and miR- 196b-5p were upregulated and miR-135b-5p was downregulated in CRC malignant tissues compared to their expression in adjacent neoplasm-free tissue. This was further observed in the plasma of the same CRC cases compared to controls. MiR-92a-3p showed itself the most sensitive (0.93; p < .001) and most specific (0.95; p < .001) in detecting CRC in tissue. In plasma, miR-196b-5p was the most sensitive (0.97; p < .001) and specific (0.94; p < .001) in detecting CRC. Plasma miR-92a-3p and miR-196b-5p were the most sensitive (0.95; p < .001) and specific (0.94; p < .001) in the early detection of CRC.Conclusions: Results show that specific miRNAs dysregulated in malignanttissues are released and can be detected in the circulation, supporting their potential as non-invasive biomarkers of CRC.Keywords
Funding Information
- Commission on Higher Education
- Philippine Association of Medical Technologists
This publication has 60 references indexed in Scilit:
- microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkersOncology Reports, 2013
- Circulating microRNAs in cancer: origin, function and applicationJournal of Experimental & Clinical Cancer Research, 2012
- Identification of aberrantly expressed miRNAs in rectal cancerOncology Reports, 2012
- Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker DesignInternational Journal of Molecular Sciences, 2012
- MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cellsCarcinogenesis, 2011
- Screening for colorectal cancer: established and emerging modalitiesNature Reviews Gastroenterology & Hepatology, 2011
- miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancerCancer Science, 2011
- Ratio of miR-196s to HOXC8 Messenger RNA Correlates with Breast Cancer Cell Migration and MetastasisCancer Research, 2010
- miRNAs as Biomarkers in Colorectal Cancer Diagnosis and PrognosisBioanalysis, 2010
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screeningGut, 2009